These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Synthesis and biological evaluation of pyrazolo[4,3-d]pyrimidine analogues. Yuan L; Song C; Li C; Li Y; Dong L; Yin S Eur J Med Chem; 2013 Sep; 67():152-7. PubMed ID: 23851116 [TBL] [Abstract][Full Text] [Related]
10. Exploring the chemical space around the privileged pyrazolo[3,4-d]pyrimidine scaffold: toward novel allosteric inhibitors of T315I-mutated Abl. Vignaroli G; Mencarelli M; Sementa D; Crespan E; Kissova M; Maga G; Schenone S; Radi M; Botta M ACS Comb Sci; 2014 Apr; 16(4):168-75. PubMed ID: 24597676 [TBL] [Abstract][Full Text] [Related]
11. Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors. Vidilaseris K; Johansson NG; Turku A; Kiriazis A; Boije Af Gennäs G; Yli-Kauhaluoma J; Xhaard H; Goldman A J Vis Exp; 2019 Nov; (153):. PubMed ID: 31814619 [TBL] [Abstract][Full Text] [Related]
12. Design and Synthesis of 2-(1-Alkylaminoalkyl)pyrazolo[1,5-a]pyrimidines as New Respiratory Syncytial Virus Fusion Protein Inhibitors. Yamaguchi-Sasaki T; Tamura Y; Ogata Y; Kawaguchi T; Kurosaka J; Sugaya Y; Iwakiri K; Busujima T; Takahashi R; Ueda-Yonemoto N; Tanigawa E; Abe-Kumasaka T; Sugiyama H; Kanuma K Chem Pharm Bull (Tokyo); 2020; 68(4):345-362. PubMed ID: 32238652 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines. Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146 [TBL] [Abstract][Full Text] [Related]
14. Pyrazolo[1,5-a]pyrimidine based Trk inhibitors: Design, synthesis, biological activity evaluation. Zhang Y; Liu Y; Zhou Y; Zhang Q; Han T; Tang C; Fan W Bioorg Med Chem Lett; 2021 Jan; 31():127712. PubMed ID: 33246108 [TBL] [Abstract][Full Text] [Related]
15. New advances in synthesis and clinical aspects of pyrazolo[3,4-d]pyrimidine scaffolds. Abdellatif KRA; Bakr RB Bioorg Chem; 2018 Aug; 78():341-357. PubMed ID: 29627655 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of a new series of pyrazolo[1,5-a]pyrimidines as CDK2 inhibitors and anti-leukemia. Almehmadi SJ; Alsaedi AMR; Harras MF; Farghaly TA Bioorg Chem; 2021 Dec; 117():105431. PubMed ID: 34688130 [TBL] [Abstract][Full Text] [Related]
17. Discovery of pyrazolo[1,5-a]pyrimidine-based Pim inhibitors: a template-based approach. Dwyer MP; Keertikar K; Paruch K; Alvarez C; Labroli M; Poker C; Fischmann TO; Mayer-Ezell R; Bond R; Wang Y; Azevedo R; Guzi TJ Bioorg Med Chem Lett; 2013 Nov; 23(22):6178-82. PubMed ID: 24091081 [TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers. Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234 [TBL] [Abstract][Full Text] [Related]
19. An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold. Cherukupalli S; Karpoormath R; Chandrasekaran B; Hampannavar GA; Thapliyal N; Palakollu VN Eur J Med Chem; 2017 Jan; 126():298-352. PubMed ID: 27894044 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and antimycobacterial evaluation of various 6-substituted pyrazolo[3,4-d]pyrimidine derivatives. Trivedi A; Vaghasiya S; Dholariya B; Dodiya D; Shah V J Enzyme Inhib Med Chem; 2010 Dec; 25(6):893-9. PubMed ID: 21054238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]